Core Laboratories Inc. (NYSE:CLB) Shares Sold by Thrivent Financial for Lutherans

Thrivent Financial for Lutherans reduced its holdings in shares of Core Laboratories Inc. (NYSE:CLB) by 5.4% during the 3rd quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor owned 36,927 shares of the oil and gas company’s stock after selling 2,094 shares during the period. Thrivent Financial for Lutherans owned approximately 0.08% of Core Laboratories worth $684,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

Several other hedge funds also recently added to or reduced their stakes in CLB. Louisiana State Employees Retirement System increased its holdings in shares of Core Laboratories by 2.2% in the second quarter. Louisiana State Employees Retirement System now owns 23,600 shares of the oil and gas company’s stock valued at $479,000 after purchasing an additional 500 shares during the period. The Manufacturers Life Insurance Company increased its holdings in shares of Core Laboratories by 3.3% in the second quarter. The Manufacturers Life Insurance Company now owns 18,054 shares of the oil and gas company’s stock valued at $366,000 after purchasing an additional 579 shares during the period. Northwestern Mutual Wealth Management Co. increased its holdings in shares of Core Laboratories by 11.9% in the second quarter. Northwestern Mutual Wealth Management Co. now owns 5,636 shares of the oil and gas company’s stock valued at $114,000 after purchasing an additional 600 shares during the period. Oppenheimer Asset Management Inc. increased its holdings in shares of Core Laboratories by 1.4% in the second quarter. Oppenheimer Asset Management Inc. now owns 54,310 shares of the oil and gas company’s stock valued at $1,102,000 after purchasing an additional 758 shares during the period. Finally, Signaturefd LLC increased its holdings in shares of Core Laboratories by 12.8% in the second quarter. Signaturefd LLC now owns 6,776 shares of the oil and gas company’s stock valued at $137,000 after purchasing an additional 767 shares during the period. 97.81% of the stock is owned by institutional investors and hedge funds.

Wall Street Analysts Forecast Growth

A number of analysts have recently commented on CLB shares. Citigroup lowered their target price on Core Laboratories from $15.00 to $14.00 and set a “sell” rating on the stock in a research note on Thursday, October 31st. StockNews.com upgraded Core Laboratories from a “sell” rating to a “hold” rating in a research report on Thursday, November 7th. Two research analysts have rated the stock with a sell rating and three have given a hold rating to the stock. Based on data from MarketBeat, Core Laboratories currently has a consensus rating of “Hold” and a consensus target price of $17.00.

Core Laboratories Price Performance

NYSE:CLB opened at $20.17 on Thursday. The stock has a 50 day moving average price of $19.56 and a 200 day moving average price of $19.61. The company has a debt-to-equity ratio of 0.55, a quick ratio of 1.79 and a current ratio of 2.48. The stock has a market cap of $946.98 million, a PE ratio of 31.97, a P/E/G ratio of 1.41 and a beta of 2.35. Core Laboratories Inc. has a one year low of $13.82 and a one year high of $25.13.

Core Laboratories (NYSE:CLB) last posted its earnings results on Wednesday, October 23rd. The oil and gas company reported $0.25 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.21 by $0.04. The company had revenue of $134.40 million during the quarter, compared to analysts’ expectations of $134.16 million. Core Laboratories had a return on equity of 15.84% and a net margin of 5.83%. The firm’s quarterly revenue was up 7.2% compared to the same quarter last year. During the same quarter last year, the firm earned $0.22 earnings per share. Equities research analysts expect that Core Laboratories Inc. will post 0.8 EPS for the current fiscal year.

Core Laboratories Announces Dividend

The firm also recently announced a quarterly dividend, which was paid on Monday, November 25th. Shareholders of record on Monday, November 4th were paid a dividend of $0.01 per share. The ex-dividend date of this dividend was Monday, November 4th. This represents a $0.04 annualized dividend and a yield of 0.20%. Core Laboratories’s dividend payout ratio (DPR) is 6.15%.

Core Laboratories Company Profile

Core Laboratories Inc provides reservoir description and production enhancement services and products to the oil and gas industry in the United States, and internationally. It operates through Reservoir Description and Production Enhancement segments. The Reservoir Description segment includes the characterization of petroleum reservoir rock and reservoir fluid samples to enhance production and improve recovery of crude oil and gas from its clients' reservoirs.